China represents a strategic priority market for many companies and investors in today’s evolving life sciences industry. Featuring the unique insights of our full-service legal team in China, this site contains valuable resources to assist clients in navigating the legal complexities of market conditions and industry trends within the region. Learn more.
In a Technology Transfer Tactics article, health care partners Tom Bulleit and Michael Lampert examined an advisory opinion from the U.S. Health and Human Services Office of Inspector General (OIG) that they believe should be highly encouraging to physician ...
IP transactions partner Hannah England (Freeman) was honored as “Practitioner of the Year: IP Transactions” in Managing Intellectual Property Americas Awards 2022. In 2021, Hannah advised on: IP licensing, collaboration and other transactional matters worth an aggregate ...
Ropes & Gray and McKinsey & Co. co-hosted a virtual roundtable meeting for regulatory affairs leaders in the medtech industry on April 22. The event included nearly 60 attendees from leading multinational medtech companies and Chinese medtech companies ...
